Cinnarizine/dimenhydrinate

Cinnarizine/dimenhydrinate, sold under the brand name Cizinate among others is a fixed-dose combination medication for the treatment of vertigo in adults.[1] It contains cinnarizine and dimenhydrinate.[1] It is taken by mouth.[1]

Cinnarizine/dimenhydrinate
Combination of
CinnarizineAntihistamine and calcium channel blocker
DimenhydrinateAntihistamine and antiemetic
Clinical data
Trade namesCizigo, Cizinate, Cizere
Pregnancy
category
Routes of
administration
By mouth
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)[1]
Identifiers
CAS Number
UNII

It was approved for medical use in Australia in December 2018.[1]

References

  1. "Cizinate ARTG ID 288566". TGA eBS. Retrieved 23 July 2020.

Further reading

  • "Cinnarizine". Drug Information Portal. U.S. National Library of Medicine.
  • "Dimenhydrinate". Drug Information Portal. U.S. National Library of Medicine.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.